Avantor (AVTR)

• Market cap: $14.4B
• 1 day: 0.90%
• 5 days: -4.16%
• 1 month: 5.31%
• 3 months: -21.42%
• 6 months: -1.58%
• Year to date: -6.77%
• 1 year: -6.65%
• 5 years: 17.90%
• 10 years: 46.28%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Employees: 14,500

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

26% more capital invested

Capital invested by funds: $13.8B [Q2] → $17.4B (+$3.6B) [Q3]

20% more funds holding in top 10

Funds holding in top 10: 10 [Q2] → 12 (+2) [Q3]

20% more repeat investments, than reductions

Existing positions increased: 201 | Existing positions reduced: 168

3.2% more ownership

Funds ownership: 96.18% [Q2] → 99.37% (+3.2%) [Q3]

1% more first-time investments, than exits

New positions opened: 80 | Existing positions closed: 79

0% more funds holding

Funds holding: 500 [Q2] → 501 (+1) [Q3]

69% less call options, than puts

Call options by funds: $75.9M | Put options by funds: $245M

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $25 18% upside
• Avg. target: $28 34% upside
• High target: $34 60% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

Wells Fargo Brandon Couillard 28% 1-year accuracy 5 / 18 met price target	32% upside $28	Overweight Maintained	28 Oct 2024
Baird Catherine Schulte 29% 1-year accuracy 6 / 21 met price target	23% upside $26	Outperform Maintained	28 Oct 2024
Barclays Luke Sergott 27% 1-year accuracy 13 / 48 met price target	18% upside $25	Overweight Maintained	25 Oct 2024
UBS Daniel Brennan 50% 1-year accuracy 3 / 6 met price target	37% upside $29	Buy Maintained	8 Oct 2024
RBC Capital Conor McNamara 26% 1-year accuracy 10 / 39 met price target	60% upside $34	Outperform Reiterated	26 Sept 2024